SciSparc Ltd.https://investorshangout.com/SciSparc-Ltd-SPRC-94888/en-usSat, 14 Nov 2026 11:18:04 GMTCopyright InvestorsHangout.comznewcar1: $SPRC 64% v22,6M C5.62 f523,778 Hod6.64 ML2.8https://investorshangout.com/post/view?id=6639436https://investorshangout.com/post/view?id=6639436Wed, 01 Nov 2023 02:52:24 GMTznewcar1: $SPRC 38% v13,2M C5.10 f521,090 Hod7.0499 ML3.15=LLhttps://investorshangout.com/post/view?id=6626005https://investorshangout.com/post/view?id=6626005Tue, 03 Oct 2023 20:22:01 GMTznewcar1: $SPRC 32% v196M C.2074 f12,898M Hod.3657 ML.1407 gap to Hod then S@.2?https://investorshangout.com/post/view?id=6623204https://investorshangout.com/post/view?id=6623204Wed, 27 Sep 2023 21:52:42 GMTznewcar1: $SPRC 23% v3,3M c.83 f7,220M H.87 ML.5027 RL.565https://investorshangout.com/post/view?id=6581518https://investorshangout.com/post/view?id=6581518Fri, 02 Jun 2023 02:08:28 GMTmojostocks: $SPRC Press release- SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strahttps://investorshangout.com/post/view?id=6580339https://investorshangout.com/post/view?id=6580339Tue, 30 May 2023 16:11:03 GMTznewcar1: SPRC 23% V91,5m C.965 F3,5m h1.45 ml=ll.61https://investorshangout.com/post/view?id=6470744https://investorshangout.com/post/view?id=6470744Wed, 14 Sep 2022 22:15:19 GMTznewcar1: SPRC 19% v66,8M c1.115 f3,5M H1.55 ML0.86https://investorshangout.com/post/view?id=6460456https://investorshangout.com/post/view?id=6460456Thu, 25 Aug 2022 03:07:30 GMTznewcar1: SPRC 41% v26M c3.33 f3,2M H3.750 preMH4.65 S2.8https://investorshangout.com/post/view?id=6411014https://investorshangout.com/post/view?id=6411014Thu, 26 May 2022 20:09:34 GMTznewcar1: SPRC 42% v15,4M c2.8 f3,2M H3.95 ML1.95https://investorshangout.com/post/view?id=6409552https://investorshangout.com/post/view?id=6409552Tue, 24 May 2022 21:09:07 GMTLee Adams: SciSparc Exploring Psychedelics as Possible Avenue to Expand Its IP Portfolio Tue, January 1https://investorshangout.com/post/view?id=6318898https://investorshangout.com/post/view?id=6318898Tue, 11 Jan 2022 15:23:19 GMTLee Adams: SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer's Dhttps://investorshangout.com/post/view?id=6315442https://investorshangout.com/post/view?id=6315442Thu, 06 Jan 2022 15:46:58 GMTLee Adams: SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disordershttps://investorshangout.com/post/view?id=6313421https://investorshangout.com/post/view?id=6313421Tue, 04 Jan 2022 14:24:53 GMTLee Adams: SciSparc Provides Updates Upon Conclusion of 2021 TEL AVIV, Israel, Dec. 29, 2021 /PRNewswhttps://investorshangout.com/post/view?id=6312639https://investorshangout.com/post/view?id=6312639Mon, 03 Jan 2022 15:02:42 GMT